Hikma's Advair Generic Gets Further Delayed Post author:Sam Post published:March 11, 2018 Post category:BioPharma Hikma Pharmaceuticals generic version of Advair has hit a stumbling block with the FDA. Source: BioSpace You Might Also Like Targovax: Invitation To First Quarter 2017 Results Presentation Tuesday 25 April April 18, 2017 Biogen Strikes $120 Million+ Deal For Remedy Pharma's Stroke Candidate May 14, 2017 Ligand To Report First Quarter 2017 Results On May 9th April 12, 2017
